Photo Credit PHIL
# 6434
Thiomersal, better known in the U.S. as thimerosal, is an organomercury compound commonly used in multi-dose vials of vaccines as a preservative. Unlike many other preservatives, it does not adversely affect the potency of the vaccine.
Its use has none-the-less been controversial, and despite reassuring data, over the past decade the United States and the European Union have been phasing out the use of Thiomersal in many pediatric vaccines in what was deemed a `purely precautionary measure’.
Eliminating Thiomersal is an expensive proposition, however. It normally requires moving to single-dose injectables - something that may be feasible in richer countries - but not easily done in the developing world.
Next week’s Weekly Epidemiological Record (7/20) will have details of a meeting between the WHO and the Global Advisory Committee on Vaccine Safety (GACVS) which met last month to discuss Thiomersal preservatives.
Today, however, we get a preview from a Q&A FAQ on Thiomersal, posted on the World Health Organization’s website.
Citing new studies that continue to show the safety of Thiomersal in vaccines, a lack of viable alternatives, and the exorbitant cost of moving to single-use injectable (which could reduce the total number of vaccinated each year), the WHO reaffirms the safety, and necessity of using Thiomersal in vaccines.
The entire FAQ: Questions and Answers on new facts and figures on vaccines and the global mercury treaty is worth reading, but they sum up their position by saying:
Based on multiple expert reviews, WHO concluded that there would be a clear risk (if reformulation with alternative preservatives or with no preservatives is required) that some products would become unavailable – particularly the current low cost vaccines.
There would be a high risk of serious disruption to routine immunization programmes and mass immunization campaigns if currently thiomersal-
preserved vaccines are not available. The consequences would be a negative health impact, due to the predictable and sizable increase in mortality through lack of access to vaccines, for very limited environmental impact.
WHO reaffirms that thiomersal-containing vaccines are very safe. They are essential and currently irreplaceable components of immunization programmes, especially in developing countries, and removal of these products would disproportionately jeopardize the health and lives of the most disadvantaged children worldwide.
Given the widespread public angst over the use of Thiomersal in vaccines (even if the scientific data doesn’t support it) - were there a viable alternative - I have to believe that this committee would have seized it.
But in a world with increasing global health problems and ever-shrinking global health budgets, moving to single-use injectables is a luxury that the WHO, and the millions of children who would be denied vaccination, simply cannot afford.
Related Post:
- Hong Kong: H5N1 Vaccine Recommended For Certain Lab Workers
- Study: Adverse Events Associated With Oseltamivir Outpatient Treatment
- MMWR: Carbon Monoxide Exposures Related To Hurricane Sandy
- Canada & Switzerland Clear Novartis Flu Vaccine For Use
- Preparing For After The Storm Passes
- NPM12: A Whole Lotta Shakeouts Going On
- NPM12: Preparedness For Kids
- NIOSH: 9/5 Is N95 Day
- H3N2v: CDC Offers Advice To Fair Goers
- MMWR: Tornado Fatalities During April 2011 Outbreak
- Study: Safety Of Drive-Thru Vaccination Clinics
- The Biggest Weather-Related Killer
- At The End Of My Rope
- CSL: Report On Febrile Reactions To FluVax
- CDC Statement On OIG Report On Vaccine Program For Children
- CDC Statement On Helmets & Tornadoes
- Reminder: Great Central U.S. Shakeout Today
- Branswell: PLoS One Study On Adverse Reactions To MMR Vaccine
- E. Coli: In the Raw (cookie dough)
- NIVW: Dec 4th – 10th, 2011
- Lancet: Guillain-Barré Syndrome & H1N1 Vaccine In Children
- IDSA: Flu Vaccines In Pregnancy
- BMJ: Another Pandemrix Study To Ponder
- Pediatrics: Effectiveness Of A Single Adjuvanted Pandemic Flu Shot In Children
- Anticipating The Flu Season Down Under
- ACP Calls For Health Care Worker Immunizations
- Branswell On Flu Vaccine Matches
- Flu Vaccine Still Available, But Spot Shortages Exist
- Study: Self-Administered Vaccines In Adults
- Egypt: A Paltry Poultry Vaccine
- Lancet: Low Flu Vaccine Effectiveness
- Hong Kong: H5N1 Vaccine Recommended For Certain Lab Workers
- AAP Endorses SAGE Recommendations Keeping Thimerosal In Vaccines
- NIVW 2012
- Study Supports Safety Of Tdap Vaccine In Older Patients
- JAMA: Waning Pertussis Vaccine Effectiveness Over Time
- Revisiting The Numbers Racket
- Of Pregnancy, Flu & Autism
- Canada & Switzerland Clear Novartis Flu Vaccine For Use
- CMAJ On Mandatory Flu Shot For HCWs
- Novartis Fluad And Agriflu Vaccines Suspended In Canada
- The UK’s Whooping Cough Outbreak
- Peter Sandman On the CCIVI Vaccine Report
- CIDRAP: The Need For `Game Changing’ Flu Vaccines
- Rhode Island Adopts New Flu Vaccination Requirements For HCPs
- Vietnam Reports Progress On New Bird Flu Vaccine
- WHO: Southern Hemisphere 2013 Flu Vaccine Composition
- NPM12: Giving Preparedness A Shot In The Arm
- Yes, We Have No Pandemic . . .
Widget by [ Iptek-4u ]